More than 15,000 vaccine doses administered yesterday;
88 in hospital & 6 in ICU; 1 death; 215 cases
發稿單位：紐西蘭衛生部
發稿時間：23 November 2021
撰 稿 者：同發稿單位
原文連結：https://bit.ly/3xeoQ4i
COVID-19單位：https://covid19.govt.nz/
統計網頁：https://bit.ly/3D5GSI5
病例 https://bit.ly/3qwLfZD
疫苗施打：https://bit.ly/3HnbrvN
There were 15,224 first and second vaccine doses administered yesterday, made
up of 4,777 first doses and 10,447 second doses. To date, 91% of eligible
people in New Zealand have had their first dose and 84% are fully vaccinated.
As of 10.30am today, more than 1,470,000 million requests for a My Vaccine
Pass had been processed.
資格人口=全人口-不符合疫苗施打條件的人
疫苗施打狀況(依據資格人口百分比)：
(全國)
總計 7,366,916 劑：3,846,920 第一劑(91%)、3,519,996 第二劑(84%)
昨日 15,224 劑： 4,777 第一劑 、 10,447 第二劑
(毛利人、太平洋原住民、各大區衛生局疫苗施打狀況詳見相關連結)
醫院病例狀況
目前總計有88名(+3)病例住院：
North Shore：19 (Waitemata)
Middlemore ：29
Auckland ：37
Waikato ： 2
Rotorua ： 1
住院病例的平均年齡是45歲
6名(+1)住ICU/HDU。
住院病例中有16名病例是突破性感染(11/23更新)
(Northern Region wards only as of 17 November)
紐西蘭本波爆發至今 7,268 例
紐西蘭疫情開始至今10,025 例
紐西蘭七日平均185位病例
紐西蘭今日新增218位病例：
北島
Auckland(奧克蘭) 6,756例(+196 含康復者2,281例)
Waikato (懷卡多)*** 361例(+ 11 含康復者 106例)
Wellington(威靈頓) 18例( 含康復者 17例)
Northland (北地) 70例(+ 4 含康復者 39例)
Bay of Plenty(富饒灣) 18例(+ 1 )
Lakes 24例(+ 2 )
Taranaki 6例(全員康復)
MidCentral* 4例(+ 1 )
Wairarapa 3例( )
南島
Nelson/Marlborough 1例(已康復)
Canterbury 7例( 含康復者 3例)
*昨日保底病例加入今日統計
***兩例改判不是病例
疫苗通行證持續推廣中
死亡案例通報：
疫情至今死亡案例通報目前41例
本波爆發死亡案例通報目前15例：
14本土(醫院10(+1)、隔離(MIQ、居家等)3、待查1)
1境外移入
Auckland City Hospital通報一名50多歲病例死亡。
11/17送醫，今日死亡回報
Clarification on COVID-19 testing, immigration status(略)
Third primary vaccine dose for immunocompromised patients
針對免疫力低下的病人要打第三劑疫苗
(這邊的用詞是Third primary vaccine dose 不是booster doses)
Updated advice from the COVID-19 Vaccine Technical Advisory Group (CVTAG) on
the third primary dose for immunocompromised patients has been published on
the Ministry of Health website.
In October, a third primary dose of the Pfizer vaccine was recommended for
individuals who are severely immunocompromised, because they are at higher
risk of severe outcomes from COVID-19 and might not produce a sufficiently
strong immune response after two doses of the vaccine.
Updated CV TAG recommendations include information about the individuals who
should be offered a third primary dose, with dialysis patients now eligible
along with the groups already identified. Guidance on how to accommodate
biologics and immunosuppressive therapies has also been added and dosage
thresholds removed to support clinical discretion.
Advice for clinicians on the guidance is available through the Immunisation
Advisory Centre, and this information will be updated periodically through
the Immunisation Handbook.
A third primary dose for severely immunocompromised people different from a
booster. A third primary dose of the Pfizer COVID-19 vaccine for severely
immunocompromised people is off-label usage and includes prescription and
consent obligations on the prescriber, the vaccinator, and the patient.
地區更新略